ASAM-magazine-Header

​ASAM Announces Partnership with ACOG to Provide Waiver Qualifying Course on Treatment for Opioid Use Disorders

by ASAM Staff | Feb 28, 2020

The American Society of Addiction Medicine (ASAM) proudly announces a collaboration with the American College of Obstetricians and Gynecologists (ACOG) to deliver the waiver qualifying ASAM Treatment of Opioid Use Disorder Course, a training with an obstetrics and gynecology focus. Twenty-six of these courses will be held nationwide through mid-2020. These courses will be made available in part by a CDC Cooperative Agreement that is “strengthening services for pregnant and postpartum women through public health clinical care partnerships.” 

This ASAM and ACOG collaboration builds on a long-standing, successful partnership that ensures that obstetrician–gynecologists have the training necessary to recognize, screen for, and treat addiction in their practices.

This course covers all medications and treatments for opioid use disorder and provides the required education needed to obtain the waiver to prescribe buprenorphine. The blended course format includes four hours of self-paced online learning and four hours of live, in-person learning. Participants are expected to complete the first online learning portion of the course before attending the live portion. This blended training satisfies the eight hours of education required for providers to qualify for a Drug Enforcement Agency DATA2000 waiver.

Nurse practitioners and physician assistants can qualify for the waiver after completing an additional 16 hours training provided by ASAM free of charge.

The courses will be held in various locations across the nation through June 2020. For the schedule and location of available courses, visit our website.

###

Features 

​ASAM Announces Partnership with ACOG to Provide Waiver Qualifying Course on Treatment for Opioid Use Disorders

by ASAM Staff | February 28, 2020

The American Society of Addiction Medicine (ASAM) proudly announces a collaboration with the American College of Obstetricians and Gynecologists (ACOG) to deliver the waiver qualifying ASAM Treatment of Opioid Use Disorder Course, a training with an obstetrics and gynecology focus. Twenty-six of these courses will be held nationwide through mid-2020. These courses will be made available in part by a CDC Cooperative Agreement that is “strengthening services for pregnant and postpartum women through public health clinical care partnerships.” 

This ASAM and ACOG collaboration builds on a long-standing, successful partnership that ensures that obstetrician–gynecologists have the training necessary to recognize, screen for, and treat addiction in their practices.

This course covers all medications and treatments for opioid use disorder and provides the required education needed to obtain the waiver to prescribe buprenorphine. The blended course format includes four hours of self-paced online learning and four hours of live, in-person learning. Participants are expected to complete the first online learning portion of the course before attending the live portion. This blended training satisfies the eight hours of education required for providers to qualify for a Drug Enforcement Agency DATA2000 waiver.

Nurse practitioners and physician assistants can qualify for the waiver after completing an additional 16 hours training provided by ASAM free of charge.

The courses will be held in various locations across the nation through June 2020. For the schedule and location of available courses, visit our website.

###

Education

​ASAM Announces Partnership with ACOG to Provide Waiver Qualifying Course on Treatment for Opioid Use Disorders

by ASAM Staff | Feb 28, 2020

The American Society of Addiction Medicine (ASAM) proudly announces a collaboration with the American College of Obstetricians and Gynecologists (ACOG) to deliver the waiver qualifying ASAM Treatment of Opioid Use Disorder Course, a training with an obstetrics and gynecology focus. Twenty-six of these courses will be held nationwide through mid-2020. These courses will be made available in part by a CDC Cooperative Agreement that is “strengthening services for pregnant and postpartum women through public health clinical care partnerships.” 

This ASAM and ACOG collaboration builds on a long-standing, successful partnership that ensures that obstetrician–gynecologists have the training necessary to recognize, screen for, and treat addiction in their practices.

This course covers all medications and treatments for opioid use disorder and provides the required education needed to obtain the waiver to prescribe buprenorphine. The blended course format includes four hours of self-paced online learning and four hours of live, in-person learning. Participants are expected to complete the first online learning portion of the course before attending the live portion. This blended training satisfies the eight hours of education required for providers to qualify for a Drug Enforcement Agency DATA2000 waiver.

Nurse practitioners and physician assistants can qualify for the waiver after completing an additional 16 hours training provided by ASAM free of charge.

The courses will be held in various locations across the nation through June 2020. For the schedule and location of available courses, visit our website.

###

MOC Guide

Considering a Career in Addiction Medicine?

Physicians who have a primary ABMS board may apply to take the ABPM Addiction Medicine exam to become or continue to be an addiction medicine specialist. Get the latest updates click here.

Advocacy and Policy

​ASAM Announces Partnership with ACOG to Provide Waiver Qualifying Course on Treatment for Opioid Use Disorders

by ASAM Staff | Feb 28, 2020

The American Society of Addiction Medicine (ASAM) proudly announces a collaboration with the American College of Obstetricians and Gynecologists (ACOG) to deliver the waiver qualifying ASAM Treatment of Opioid Use Disorder Course, a training with an obstetrics and gynecology focus. Twenty-six of these courses will be held nationwide through mid-2020. These courses will be made available in part by a CDC Cooperative Agreement that is “strengthening services for pregnant and postpartum women through public health clinical care partnerships.” 

This ASAM and ACOG collaboration builds on a long-standing, successful partnership that ensures that obstetrician–gynecologists have the training necessary to recognize, screen for, and treat addiction in their practices.

This course covers all medications and treatments for opioid use disorder and provides the required education needed to obtain the waiver to prescribe buprenorphine. The blended course format includes four hours of self-paced online learning and four hours of live, in-person learning. Participants are expected to complete the first online learning portion of the course before attending the live portion. This blended training satisfies the eight hours of education required for providers to qualify for a Drug Enforcement Agency DATA2000 waiver.

Nurse practitioners and physician assistants can qualify for the waiver after completing an additional 16 hours training provided by ASAM free of charge.

The courses will be held in various locations across the nation through June 2020. For the schedule and location of available courses, visit our website.

###

Alcohol withdrawl management

Guideline on Alcohol Withdrawal Management

The ASAM Guideline on Alcohol Withdrawal Management is intended to aid clinicians in their clinical decision making and management of patients experiencing alcohol withdrawal syndrome.

web-hero-BEST

Board Exam Study Tool

The ASAM Board Examination Study Tool (BEST) helps prepare physicians for the ABPM certification/re-certification examination utilizing an interactive and engaging format. Includes over 700 board-style self-assessment questions and developed, reviewed and mapped to the ABPM exam blueprint content areas by national experts. Learn More>>>

ASAM Weekly Commentary

​ASAM Announces Partnership with ACOG to Provide Waiver Qualifying Course on Treatment for Opioid Use Disorders

by ASAM Staff | February 28, 2020

The American Society of Addiction Medicine (ASAM) proudly announces a collaboration with the American College of Obstetricians and Gynecologists (ACOG) to deliver the waiver qualifying ASAM Treatment of Opioid Use Disorder Course, a training with an obstetrics and gynecology focus. Twenty-six of these courses will be held nationwide through mid-2020. These courses will be made available in part by a CDC Cooperative Agreement that is “strengthening services for pregnant and postpartum women through public health clinical care partnerships.” 

This ASAM and ACOG collaboration builds on a long-standing, successful partnership that ensures that obstetrician–gynecologists have the training necessary to recognize, screen for, and treat addiction in their practices.

This course covers all medications and treatments for opioid use disorder and provides the required education needed to obtain the waiver to prescribe buprenorphine. The blended course format includes four hours of self-paced online learning and four hours of live, in-person learning. Participants are expected to complete the first online learning portion of the course before attending the live portion. This blended training satisfies the eight hours of education required for providers to qualify for a Drug Enforcement Agency DATA2000 waiver.

Nurse practitioners and physician assistants can qualify for the waiver after completing an additional 16 hours training provided by ASAM free of charge.

The courses will be held in various locations across the nation through June 2020. For the schedule and location of available courses, visit our website.

###

JAM Podcast

Journal of Addiction Medicine March/April 2020

In episode sixteen of Addiction Medicine: Beyond the Abstract, we are joined by Itai Danovitch, MD, MBA. He is the chairman of the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center in Los Angeles. In his paper, Dr. Danovitch discusses some of the challenges facing the study of opioid overdose events in the hospital setting.

Click to listen